EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Development of intestinal organoids and microphysiological systems and their application to drug discovery

Takahiro Iwao, Tamihide Matsunaga

Drug Metabolism and Pharmacokinetics · 2025

DOI: 10.1016/j.dmpk.2024.101045 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Metabolism and Pharmacokinetics, 2025. Verfasst von Takahiro Iwao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Nagoya City University, Japan. Electronic address: tiwao@phar.nagoya-cu.ac.jp. Hauptthemen laut MEDLINE: Organoids, Drug Discovery, Intestines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nagoya City University, Japan Society for the Promotion of Science, Japan Research Foundation for Clinical Pharmacology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intestines are an important organ with a variety of functions. For drug discovery research, experimental animals and Caco-2 cells derived from a human colon carcinoma may be used to evaluate the absorption and safety of orally administered drugs. These systems have issues, such as species differences with humans in experimental animals, variations in gene expression patterns, very low drug-metabolizing activities in Caco-2 cells, and the recent trend toward reduced animal testing. Thus, there is a need for new evaluation systems. Intestinal organoid technology and microphysiological systems (MPS) have attracted attention as novel evaluation systems for predicting drug disposition, safety, and efficacy in humans in vitro. Intestinal organoids are three-dimensional structures that contain a variety of intestinal cells. They also contain crypt-villus structures similar to those of living bodies. Using MPS, it is possible to improve the functionality of cells and evaluate the linkage and crosstalk between the intestine and the liver. These systems are expected to be powerful tools for drug discovery research to predict efficacy and toxicity in humans. This review outlines the current status of intestinal organoids and MPS studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsDrug DiscoveryIntestinesHumansAnimalsIntestinal MucosaMicrophysiological Systems

Stichwörter der Autor:innen

Drug discoveryInduced pluripotent stem cellIntestinal organoidMicrophysiological systemPrimary enterocyte

Autor:innen und Institutionen

  • Graduate School of Pharmaceutical Sciences, Nagoya City University, Japan. Electronic address: tiwao@phar.nagoya-cu.ac.jp.
  • Graduate School of Pharmaceutical Sciences, Nagoya City University, Japan. Electronic address: tmatsu@phar.nagoya-cu.ac.jp.

Förderung

  • Nagoya City University
  • Japan Society for the Promotion of Science
  • Japan Research Foundation for Clinical Pharmacology
  • Japan Agency for Medical Research and Development

Zitieren

APA

Iwao, T., & Matsunaga, T. (2025). Development of intestinal organoids and microphysiological systems and their application to drug discovery. Drug Metabolism and Pharmacokinetics. https://doi.org/10.1016/j.dmpk.2024.101045

Vancouver

Iwao T, Matsunaga T. Development of intestinal organoids and microphysiological systems and their application to drug discovery. Drug Metabolism and Pharmacokinetics. 2025. doi:10.1016/j.dmpk.2024.101045

BibTeX
@article{Iwao2025,
  author = {Iwao, Takahiro and Matsunaga, Tamihide},
  title = {Development of intestinal organoids and microphysiological systems and their application to drug discovery},
  journal = {Drug Metabolism and Pharmacokinetics},
  year = {2025},
  doi = {10.1016/j.dmpk.2024.101045}
}
Kostenlos starten →